These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 873648)

  • 1. Biological characterization of a tumour-growth-promoting factor from ascitic fluid of tumour-bearing mice.
    Henriksen TO; Law LW
    Int J Cancer; 1977 Jun; 19(6):866-9. PubMed ID: 873648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W; Graetz H; Schütt M; Langen P
    Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.
    Wilson AP; Fox H; Scott IV; Lee H; Dent M; Golding PR
    Br J Cancer; 1991 Jan; 63(1):102-8. PubMed ID: 1989647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employment of synchronized cells and flow microfluorometry in investigations on the JB-1 ascites tumour chalones.
    Bichel P; Barfod NM; Jakobsen A
    Virchows Arch B Cell Pathol; 1975 Nov; 19(2):127-33. PubMed ID: 127415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between three subpopulations of Ehrlich carcinoma in mixed solid tumours in nude mice: evidence of contact domination.
    Aabo K; Vindeløv LL; Spang-Thomsen M
    Br J Cancer; 1994 Jul; 70(1):91-6. PubMed ID: 8018547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of macrophages grown in tumorous ascitic fluid.
    Yamazaki M; Ikenami M; Yui S; Esumi-Kurisu M; Mizuno D
    Gan; 1983 Feb; 74(1):155-61. PubMed ID: 6840434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.
    Mills GB; May C; Hill M; Campbell S; Shaw P; Marks A
    J Clin Invest; 1990 Sep; 86(3):851-5. PubMed ID: 2394835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative studies of natural immunity to solid tumours in rats. NK activity in animals with primary or transplanted spontaneous tumours.
    Flannery GR; Brooks CG
    Int J Cancer; 1981 Dec; 28(6):747-55. PubMed ID: 7333706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syngeneic serum and ascitic fluid in enzymatically produced tumour cell suspensions. II. Effects on experimental metastases.
    Boeryd B; Knutson F; Lundin PM; Norrby K
    Pathol Eur; 1971; 6(1):43-9. PubMed ID: 5550665
    [No Abstract]   [Full Text] [Related]  

  • 11. Endogenous tumor growth factor indicated by increased ornithine decarboxylase activity in malignant cells treated with host serum ascites fluid.
    Vaage J; Agarwal S
    Cancer Res; 1979 May; 39(5):1511-7. PubMed ID: 427794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.
    Wolf A; Steele KA
    Br J Cancer; 1975 Jun; 31(6):684-8. PubMed ID: 1174446
    [No Abstract]   [Full Text] [Related]  

  • 13. The growth characteristics of an ascitic plasmacytoma (MP 5563) terminating by fistulous communication with the blood-stream.
    Fakhri O
    Br J Cancer; 1970 Jun; 24(2):389-94. PubMed ID: 5456739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.
    Howell SB; Dean JH; Law LW
    Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour responses induced by short-term pretreatment with tumour cells.
    James K; Cullen RT; Milne I; Norval M
    Br J Cancer; 1978 Feb; 37(2):269-81. PubMed ID: 629863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.
    Wolf A; Steele KA; Alexander P
    Br J Cancer; 1976 Feb; 33(2):144-53. PubMed ID: 1259913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-tumour relationship. XXV. Hyaluronidase activity in blood serum and ascitic fluid of rats during growth of transplanted tumours.
    Kolárová M; Brada Z
    Neoplasma; 1969; 16(4):377-87. PubMed ID: 4310101
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific chalone inhibition of the regeneration of the JB-1 ascites tumour studied by flow microfluorometry.
    Bichel P; Barfod NM
    Cell Tissue Kinet; 1977 Mar; 10(2):183-93. PubMed ID: 140007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
    Chang RW; Turk JL
    Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific growth regulation in three ascitic tumours.
    Bichel P
    Eur J Cancer (1965); 1972 Apr; 8(2):167-73. PubMed ID: 5073291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.